Ligne de temps

Mathieu Mateo
Chercheur(euse) Permanent(e)
09 Jun 2021
publication

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

Lire plus
04 Jan 2021
publication

Systemic viral spreading and defective host responses are associated with fatal Lassa fever in macaques.

Lire plus
01 Dec 2020
publication

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus.

Lire plus
01 May 2020
publication

Modeling Favipiravir Antiviral Efficacy Against Emerging Viruses: From Animal Studies to Clinical Trials.

Lire plus
03 Jan 2020
publication

Rational design of universal immunotherapy for TfR1-tropic arenaviruses.

Lire plus
01 Dec 2019
publication

A 40-Month Follow-Up of Ebola Virus Disease Survivors in Guinea (PostEbogui) Reveals Long-Term Detection of Ebola Viral Ribonucleic Acid in Semen and Breast Milk.

Lire plus
02 Oct 2019
publication

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot.

Lire plus
01 Sep 2019
publication

Fatal Case of Lassa Fever, Bangolo District, Côte d’Ivoire, 2015

Lire plus
23 Mar 2019
publication

Autophagy Promotes Infectious Particle Production of Mopeia and Lassa Viruses

Lire plus
21 Mar 2019
publication

Non-Pathogenic Mopeia Virus Induces More Robust Activation of Plasmacytoid Dendritic Cells than Lassa Virus

Lire plus
10 Jan 2019
publication

Immune parameters and outcomes during Ebola virus disease

Lire plus
12 Nov 2018
publication

Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells

Lire plus
01 Oct 2018
publication

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies

Lire plus
29 May 2018
publication

A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins

Lire plus
28 Sep 2017
publication

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs

Lire plus
15 Jun 2017
publication

Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea

Lire plus
23 Mar 2017
publication

Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea

Lire plus
23 Feb 2017
publication

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

Lire plus
14 Jan 2017
publication

Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study

Lire plus
18 Dec 2016
publication

Ocular Complications in Survivors of the Ebola Outbreak in Guinea

Lire plus
14 Nov 2016
publication

Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies

Lire plus
03 May 2016
publication

New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors

Lire plus
05 Apr 2016
publication

Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Lire plus
01 Mar 2016
publication

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

Lire plus
07 Jan 2016
publication

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

Lire plus
16 Dec 2015
publication

[Viral zoonoses and emergence: research is just starting]

Lire plus
21 Jul 2015
publication

Severe Ebola Virus Infection With Encephalopathy: Evidence for Direct Virus Involvement

Lire plus
19 Jul 2015
publication

Towards deep insight into Ebola virus disease

Lire plus
03 Jul 2015
project

Lassa fever

Lire plus
11 May 2015
team

Biologie des infections virales émergentes

Lire plus
06 Feb 2015
publication

Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus

Lire plus
01 Jan 2015
publication

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Lire plus
24 Nov 2014
publication

Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014

Lire plus
19 Nov 2014
publication

Ebola: should we consider influenza vaccination?

Lire plus
24 Sep 2014
publication

Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response

Lire plus
24 Sep 2014
publication

The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses

Lire plus
16 Apr 2014
publication

Emergence of Zaire Ebola virus disease in Guinea

Lire plus
09 Jan 2014
publication

Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever

Lire plus
05 Nov 2012
publication

Immune responses and Lassa virus infection

Lire plus
01 Jul 2012
publication

NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression

Lire plus
31 Aug 2011
publication

Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages

Lire plus
01 Jun 2011
publication

Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus

Lire plus
09 Feb 2011
publication

Evidence for Ebola virus superantigen activity

Lire plus
05 Oct 2010
publication

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

Lire plus
01 Oct 2010
publication

Towards broad protection against Ebolaviruses

Lire plus
18 Mar 2009
publication

Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys

Lire plus
20 Mar 2006
publication

Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages

Lire plus
01 Jul 2005
publication

A single shot against Ebola and Marburg virus

Lire plus
01 Oct 2004
publication

Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection

Lire plus
01 Mar 2004
publication

Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells

Lire plus
01 Dec 2003
publication

[Ebola hemorrhagic fever: a unique efficacious vaccine dose in primates]

Lire plus